|
As on 25-Jan-2021
|
|
|
|
Quarterly Results & Inter alia, to consider and approve 2. The proposal of listing of equity shares of the Company on National Stock Exchange of India Limited (?NSE?) through direct listing mode; 3. The proposal of change of name of the Company.
|
|
|
|
|
|
|
Inter alia to: ? To take note of sad and sudden demise of Mr. Mukesh Chimanlal Gandhi, Co-Promoter, Whole-time Director & CFO of the Company; ? To re-constitute various Committees of the Company; and ? Such other business.
|
|
|
|
|
|
|
Resolution Plan -Extinguishment of equity and delisting
|
|
|
|
|
|
|
Inter alia, to approve the appointment of additional director of the Company.
|
|
|
|
|
|
|
Preferential Issue of shares & Rights Issue Inter alia, to consider and approve a proposal for raising of fund by way of issue of one or more instruments comprising of equity shares, convertible securities of any other description or warrants or debt securities, through Private Placement/ Preferential Issue/ Qualified Institutions Placement/ or such other methods/ combinations thereof as may be decided by the Board, subject to such statutory/ regulatory approvals as may be necessary including the approval of shareholders of the Company, wherever required. The Board, if required, would also consider conducting an Extraordinary General Meeting/ Postal Ballot to seek shareholders? approval inter alia in respect of the aforesaid proposal(s), if the same are approved by the Board.
|
|
|
|
|
|
|
Ahlada Engineers Limited has informed the Exchange regarding Resignation of Mr Bhaskara Reddy Nallapureddy as Independent Director of the company w.e.f. January 23, 2021.
|
|
|
|
|
|
|
Ajooni Biotech Limited has informed the Exchange regarding 'Outcome of the Board Meeting held on 23rd January 2021, Saturday.'.
|
|
|
|
|
|
|
Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on January 23, 2021. 1. Increase in Authorised Capital 2. Issue of Bonus Shares 3. Migration of the company from SME platform to Main Board of NSE. 3. Approval of Postal Ballot Notice. 4. Appointment of Scrutiniser. 5. Approval of Cut-off date
|
|
|
|
|
|
|
Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on January 23, 2021. 1. Increase in Authorised Capital 2. Issue of Bonus Shares 3. Migration of the company from SME platform to Main Board of NSE. 3. Approval of Postal Ballot Notice. 4. Appointment of Scrutiniser. 5. Approval of Cut-off date
|
|
|
|
|
|
|
Baba Agro Food Limited has informed the Exchange regarding Board meeting held on January 22, 2021.
|
|
|
|
|
|
|
South West Pinnacle Exploration Limited has informed the Exchange regarding 'Submission of Newspaper Advertisement pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.
|
|
|
|
|
|
|
Vertoz Advertising Limited has informed the Exchange regarding 'Intimation of incorporation of branch of our Subsidiary Company in New Jersey, USA'.
|
|
|
|
|
|
|
Airan Limited has informed the Exchange regarding 'Certificate under Regulation 74 (5) of SEBI ( Depositories and Participants)Regulations, 2018 for the quarter ended 31st December, 2020'.
|
|
|
|
|
|
|
Preferential Issue of shares Inter alia, to consider and approve further issue of Shares/ other convertible securities on preferential basis.
|
|
|
|
|
|
|
With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Midodrine Hydrochloride Tablets USP, 2.5 mg, 5 mg, and 10 mg. Please find enclosed herewith our press release. We request you to kindly take the same on record.
|
|
|
|
|
|
|
|
|
|
|
|